ARYA SCIENCES ACQUISITION CORP.

ARYA Sciences Acquisition Corp. (Nasdaq: ARYA) is a blank-check company sponsored by Perceptive Advisors, a specialist healthcare investment firm, that completed its initial public offering in 2019 with a stated mandate to pursue a business combination in the life sciences and biotechnology sector. As reflected in its August 2019 10-Q filing with the SEC, the company was operating in its post-IPO search phase, identifying and evaluating acquisition candidates across the biopharma and broader life sciences landscape. Perceptive Advisors, widely recognized for its deep domain expertise in healthcare investing, anchored the SPAC's sponsorship team. For full filing histories, sponsor track records, and deal timelines on ARYA and hundreds of other SPACs, sign up for complete access at SpacDesk.